StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 08/15/2013 -- StockRunway.com issues special report on - Medora Corp(OTCMKTS:XUII), Eastman Kodak Company(OTCMKTS:EKDKQ), Patient Safety Technologies Inc(OTCMKTS:PSTX), STELLAR BIOTECH INC(OTCMKTS:SBOTF)
Medora Corp(OTCMKTS:XUII) ended its day with the gaining stream with the gain of +7.46% and closed at the price of $0.0720 after opening at $0.08. Stock traded during its last trading session with the total traded volume of 2.73 million shares as compared to its average volume of 21.10 million shares.
During last 5 trades the stock plummeted almost -81.91%, and during last one month it slipped/ rose with the percentage of -81.91. XUII’s total market capitalization is $22.87 million along with 341,300,300 shares outstanding. Xumanii International Holdings Corp provides online live content streaming services through its Website, xumanii.com. It also offers an embedded player for placing on other Websites for streaming, as well as Xumanii-Facebook application to enable the producer?s viral marketing promotion for their events. The company enables its users to set a price and sell digital tickets, access sponsorship support for their live production by giving the option to sell banner space on profile page; and add pre-recorded commercials to their live streaming content. The company was formerly known as Xumanii, Inc. and changed its name to Xumanii International Holdings Corp in July 2013. Xumanii International Holdings Corp was founded in 2010 and is based in Kingston, Jamaica.
For How Long XUII’s Gloss will Attract Investors? Find out via this report
Eastman Kodak Company(OTCMKTS:EKDKQ) opened its shares at the price of $0.12 for the day, its closing price was $0.111 after losing -7.99% for the day. The company traded with the total volume of 1.74 million shares while its average trading aptitude remained 1.71 million shares. The beta of the EKDKQ stands at 1.80.Its year to date performance remained adverse with -38.27%.
The company has total of 272.78 million outstanding shares and its total market capitalization is $30.14 million. Eastman Kodak Company engages in commercial imaging business. It operates through three segments: the Graphics, Entertainment and Commercial Films (GECF); the Digital Printing and Enterprise (DP&E); and the Personalized and Document Imaging (P&DI).
Why Should Investors Buy EKDKQ After the Recent Fall? Just Go Here and Find Out
Patient Safety Technologies Inc(OTCMKTS:PSTX) stock is at $2.10, up +2.44 percent from its previous close of $2.05. The stock opened the session at $2.10 and touched its highest price point at $2.20. PSTX stock’s lowest price point for the session stood at $2.091.
Stocks graphical chart shows a bearish trend during its last one month’s trading session. It remained positive with +27.27% during previous three months trade. Its recent trading volume was 87,549.00 shares in comparison to its usual trading volume of 45,061.00 shares. Patient Safety Technologies, Inc., through its subsidiary, SurgiCount Medical, Inc., engages in the development, marketing, and sale of products; and the provision of services in the medical patient safety markets in the United States.
Will PSTX Continue To Move Higher? Find Out Here
STELLAR BIOTECH INC(OTCMKTS:SBOTF) experienced a upsurge of +0.75% to a market valuation of $69.85M per share for previous trading session. After opening the day at $1.33 per share, volume surged to 261,293.00 . The stock remained in $1.26 and $1.34 price range during the session
During last 5 trades the stock jumped almost +35.2%. During last one month it rose with the percentage of +75.97. Its year to date performance remained progressive with +356.68%. Stellar Biotechnologies, Inc. produces and markets keyhole limpet hemocyanin (KLH), as well as develops technology related to the culture and production of KLH and subunit KLH formulations in the United States and Europe. The company?s KLH is an immunogenic high-molecular-weight protein, which is used in cancers and therapeutic vaccines for lymphoma, bladder, breast, colon, and other cancers. Its KLH products include pharmaceutical intermediates and research regents, as well as products for vaccine conjugation. The company also provides KLH ELISA test kits used for the quantitative measure of anti-KLH antibodies in serum or plasma samples. Stellar Biotechnologies, Inc. is headquartered in Port Hueneme, California.
Why Should Investors Buy SBOTF After The Recent Gain? Just Go Here and Find Out
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)